Search Results

AI-Enhanced MRI System Deployed at Utah Medical Center for Cardiac and Cancer Imaging

Intermountain Medical Center in Murray, Utah, has begun using a new magnetic resonance (MR) system for imaging cardiac and cancer patients. The facility stated that the GE HealthCare SIGNA Sprint Elite MR system was placed into service earlier this year, making it the first of its kind in Utah and the second in the United States. According to the hospital, the system integrates artificial intelligence software designed to reduce image noise and enhance scan clarity. The facility believes that clearer images will help clinicians assess cardiac tissue and cancer-related conditions, while also potentially reducing the time patients spend undergoing MR exams. Cardiac imaging is one of the system's key application areas.

2026-09-02

XENONnT Dark Matter Detector Captures Faintest Solar Neutrino Signal Ever Observed

September 1 news - The XENONnT dark matter detection experiment at the Gran Sasso National Laboratory in Italy has achieved new progress. The XENON collaboration research team announced that the detector has captured low-energy solar neutrino collision signals never observed before, lowering the neutrino detection energy threshold to approximately 17 kiloelectron-volts (keV). The research team's analysis indicates that the probability of the signal being merely a statistical fluctuation is less than one in a million. Neutrinos are elementary particles with no electric charge and extremely small mass, which can be produced in processes such as nuclear fusion reactions in the solar core, supernova explosions, and nuclear fission in reactors. Due to the extremely weak interaction between neutrinos and matter, vast numbers of neutrinos can pass through the Earth, which also makes detection...

2026-09-02

Prostate cancer becomes most common cancer among men in South Korea, Lu-177 PSMA therapy reaches cumulative 200 procedures

Prostate cancer incidence in South Korea has continued to rise, making it the most common cancer among men in the country. Meanwhile, a novel nuclear medicine treatment for metastatic prostate cancer—Lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA) radioligand therapy—is accumulating more clinical cases. Seoul St. Mary's Hospital Uro-Oncology Center stated on September 1 that since performing South Korea's first Lu-177 PSMA treatment on November 2, 2020, the center had administered a cumulative total of 200 such treatments to 84 patients with metastatic prostate cancer as of the 21st of last month. Metastatic castration-resistant prostate cancer refers to a state in which prostate cancer continues to progress despite androgen suppression therapy. As the disease advances, patients have fewer treatment options and a worse prognosis, making it essential to select appropriate treatment modalities and sequencing based on prior treatment history and physical condition.

2026-09-02

Carbon Nanotubes Can "Remember" Their Initial Structure, Isotope Labeling Reveals Dynamic Growth Process

A study released on September 1 shows that carbon nanotubes can maintain their initial atomic structure in dynamically changing growth environments. The research team used digital isotope labeling technology to encode the elongation process of individual carbon nanotubes as sequences of different carbon isotope compositions, and read their growth history through Raman spectroscopy, thereby tracking the structural stability of nanotubes under conditions of temperature variation and catalyst evolution. The properties of carbon nanotubes are highly dependent on their atomic arrangement. The same material may exhibit metallic or semiconducting characteristics due to structural differences, so structural uniformity has always been a key issue for the large-scale application of carbon nanotubes. In floating catalyst chemical vapor deposition and other industrial production routes, catalyst particles experience constantly changing temperatures and gas compositions within the reactor and may undergo irreversible enlargement. Previously, direct evidence was lacking on whether individual carbon nanotubes could maintain their initial structure under such complex conditions.

2026-09-02

Japanese Team Develops High-Temperature, High-Pressure Isotope Ratio Analysis Method for Tracing Halogenated Pollutants

Researchers from Shibaura Institute of Technology (SIT) and the National Institute of Advanced Industrial Science and Technology (AIST) in Japan have collaboratively developed a customized high-temperature, high-pressure combustion interface for liquid chromatography-isotope ratio mass spectrometry (LC-IRMS), enabling carbon stable isotope ratio (δ¹³C) analysis of various halogenated organic compounds. The research findings were published online on August 2, 2026, and will appear in Volume 1421 of Analytica Chimica Acta, scheduled for release on November 1, 2026. Source of the new high-temperature, high-pressure LC-IRMS system: Professor Hiroto Kawashima, SIT, Japan. Halogenated organic compounds are widely present in disinfection byproducts, pesticides, refrigerants, and industrial chemicals, some of which exhibit persistence, bioaccumulation, and toxicity. Traditional environmental monitoring primarily relies on concentration measurements, which makes it difficult to directly provide information on pollutant sources and environmental transformation processes. δ¹³C analysis can offer clues for studying chemical sources, production processes, and environmental fate, but organic pollutants containing strong carbon—chlorine or carbon—fluorine bonds are difficult to fully oxidize under conventional LC-IRMS combustion conditions, limiting the application of this technique.

2026-09-02

Iran Still Denies IAEA Inspectors Access to Some Nuclear Facilities

A recent report shows that Iran has still not allowed International Atomic Energy Agency (IAEA) inspectors to access some of its nuclear facilities, including sites in Isfahan, Natanz, and Fordow that were previously damaged in airstrikes. The report states that the IAEA had previously detected over 440 kilograms of highly enriched uranium and nearly 8,600 kilograms of low-enriched uranium at these locations. Due to the current lack of sufficient information on the status and whereabouts of the relevant nuclear materials, IAEA Director General Rafael Grossi has expressed concerns over nuclear non-proliferation risks and called on Tehran to allow inspectors to access the facilities for verification as soon as possible. The report also mentions that inspectors...

2026-09-02

US Antares to Apply Racing Power Electronics to Microreactors

Antares, a US nuclear fission energy company, recently announced a partnership with UK technology supplier Motion Applied to deploy the latter's race-proven power electronics in its microreactor power conversion system. According to Antares, Motion Applied has long served motorsport and other demanding applications, accumulating expertise in high-performance electronics and electrification technologies. This collaboration will enable Antares to use more mature, production-grade hardware in its microreactor program, reducing the time and cost associated with developing dedicated power conversion equipment from scratch. Antares Chief Nuclear Officer Ri...

2026-09-02

Canadian Indigenous-led Transportable Nuclear Power Plant Project Planned for Early 2030s Operation

Pabineau First Nation, Eel River Bar First Nation, and Prodigy Clean Energy recently announced that they will advance an Indigenous-led new nuclear power project in Belledune, New Brunswick, Canada. Under the relevant exclusive agreements, the parties plan to deploy a full-size transportable nuclear power plant (TNPP) with a capacity of up to 50 megawatts within the traditional territories of Pabineau First Nation and Eel River Bar First Nation. The pilot project, intended to be owned by the First Nations, is primarily aimed at validating the logistics organization and op...

2026-09-02

Ionetix begins routine supply of astatine-211 in North America, expanding sources of isotopes for targeted alpha therapy

Ionetix, a U.S. medical isotope producer, recently announced that it has begun routine supply of astatine-211 (At-211) in North America. The company stated that this development expands the supply sources of At-211 and is expected to support its further application in preclinical research and clinical development. Ionetix noted that it believes it is the first non-academic commercial supplier of At-211 in the United States. Ionetix produces At-211 at its facility in Lansing, Michigan, leveraging its proprietary cyclotron technology. The company currently operates a 30 MeV cyclotron equipped with optimized target technology, aiming to support the production of clinical-grade At-211. The company stated that its production ca...

2026-09-02

FDA Grants Breakthrough Therapy Designation to JBS-003 for Guiding De-escalated Radiotherapy in HPV-Positive Oropharyngeal Cancer

On September 1, Juniper Biosciences announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to its hypoxia tracer JBS-003. The product, 18F-Fluoromisonidazole (FMISO), is intended to identify tumor hypoxia and guide de-escalated radiotherapy in patients with HPV-positive oropharyngeal cancer (OPC). JBS-003 is licensed from Memorial Sloan Kettering Cancer Center (MSK). According to information released by the company, the tracer is based on F-MISO PET molecular imaging technology and can visualize specific hypoxic features within tumors. Tumor hypoxia is considered to be associated with radioresistance; by imaging hypoxic regions, clinicians can stratify patients by risk and...

2026-09-02

NewHydrogen Files Third Patent Application for ThermoLoop Hydrogen Production Technology

NewHydrogen, Inc. recently announced that it has filed a third provisional patent application jointly with the University of California, Santa Barbara (UCSB) to protect developments related to its clean hydrogen production technology, ThermoLoop. The patent application is titled "Isothermal Chemical Looping Hydrogen Production." According to NewHydrogen, the application builds on two previous patents and covers the latest improvements to the ThermoLoop thermochemical water-splitting process, as well as novel material compositions discovered by the UCSB technical team. The process produces hydrogen by splitting water using thermal energy, combined with advanced solid-state materials and machine learning-driven materials discovery methods to improve efficiency and cost-effectiveness...

2026-09-02

Canada's Devonian Integrates HPLC-MS, NMR, and Cell-Based Potency Assays into Thykamine Quality Control Platform

Devonian Health Group Inc., a Canadian clinical-stage biopharmaceutical company, recently announced that it has completed independent validation of key analytical methods and biological quality control technologies and integrated them into the extraction and production process of Thykamine, the company's lead active pharmaceutical botanical candidate. According to the company, its quality control program includes validated high-performance liquid chromatography-mass spectrometry (HPLC-MS) chemical fingerprinting, nuclear magnetic resonance (NMR) spectroscopy, and cell-based biological potency assays based on the U937 human cell line. The relevant cell-based assays use macrophage inflammatory protein-1β (MIP-1β) as a biomarker of Thykamine's anti-inflammatory activity...

2026-09-02

South Korea's 2027 Budget Proposal Includes First-Ever Funding for Domestic Nuclear Submarine Development

The South Korean government approved its 2027 budget proposal, with total government spending reaching 820.9 trillion won, approximately 95.6 trillion yen, marking a 12.8% increase from the previous year and setting a record high. The budget proposal has been submitted to the National Assembly for review. President Lee Jae-myung presided over a cabinet meeting at the presidential office on September 1, where the budget proposal was reviewed and approved. Under the plan, the South Korean government intends to increase investment in growth-oriented industries, with approximately 2.5 trillion yen allocated to infrastructure development related to semiconductor manufacturing and artificial intelligence, nearly doubling the scale of the previous year. On the revenue side, the South Korean government expects that as AI demand continues to grow and major semiconductor companies see improved performance, corporate income tax and personal income tax revenues will increase significantly.

2026-09-02

Japan's Tomari Nuclear Power Plant Plans New Low-Level Radioactive Waste Processing Facility

Hokkaido Electric Power Company (HEPCO) recently announced plans to construct a new low-level radioactive waste processing facility within the premises of the Tomari Nuclear Power Plant in Hokkaido, Japan, to handle approximately 12,000 drums of low-level radioactive waste currently stored on site. According to HEPCO, the new facility will sort waste such as paper and metal, reduce its volume through fine shredding or compression, and then solidify it by pouring mortar into the waste drums. After processing, the waste will undergo radioactivity level testing before being transported to the disposal center in Rokkasho Village, Aomori Prefecture. Previously, the Tomari plant had stored this type of waste in 200-liter drums without further processing. The proposed facility will have an annual processing capacity of over 1,000 drums, feature a three-story structure, and cover a total floor area of approximately 4,600 square meters.

2026-09-02

Japan's Onagawa Nuclear Power Station Unit 2 Plans to Replace Hydrogen Concentration Monitoring Equipment

Tohoku Electric Power has consulted with Miyagi Prefecture, Ishinomaki City, and Onagawa Town in advance regarding a change to the method of monitoring hydrogen concentration inside the containment vessel under severe accident conditions at Unit 2 of the Onagawa Nuclear Power Station. The company plans to submit an application to amend the reactor installation license to the Nuclear Regulation Authority (NRA) of Japan on the 2nd. Unit 2 of the Onagawa Nuclear Power Station is located in Onagawa Town and Ishinomaki City, Miyagi Prefecture. Tohoku Electric Power previously installed a total of four hydrogen concentration detectors inside and outside the reactor containment vessel of this unit, intended to monitor changes in hydrogen concentration within the containment vessel in the event of a severe accident. In 2025, some of these detectors experienced malfunctions. In the same year...

2026-09-02